Startup targeting protein degradation in cancer raises $37M
Cleave Biosciences is trying to prevent protein degradation, a hallmark of certain cancers, in its aim to develop drugs that work on solid tumors and blood cancers.
Cleave Biosciences is trying to prevent protein degradation, a hallmark of certain cancers, in its aim to develop drugs that work on solid tumors and blood cancers.